JPRN-UMIN000005113已完成4 期
Evaluation of the clinical remission and its sustainment after discontinuation of infliximab in patients with rheumatoid arthritis who receive "programmed" treatment in randomized controlled trial - Remission induction by Raising the dose of Remicade in RA study (RRRR Study)
niversity of Occupational and Environmental Health, Japan0 个研究点目标入组 450 人开始时间: 2011年3月31日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 450
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) patients who use steroid over 10mg/day (prednisolone-equivalent), 2) SDAI =< 11.0, 3) severe infection, 4) active tuberculosis, 5) demyelinating disease, 6) congestive heart failure, 7) Patient who is lactating, pregnant, possibly pregnant or do not agree with anti-conception during the trial and 6 month after the last administration of IFX, 8) patients who are inadequate to enter this trial due to the other reasons by physician's judgments
研究者
相似试验
尚未招募
不适用
Examination of the clinical remission and functional remission in Infliximab using the increase-in-quantity protocol to TNF-alpha inhibitory drug resistance rheumatoid arthritisrheumatoid arthritisJPRN-UMIN000014311Institute of Health Biosciences, The University of Tokushima Graduate School10
已完成
不适用
Objective assessment of the remission state and Predictors of sustained Remission in Rheumatoid Arthritis: leading to development of new management guidelinesRheumatoid arthritisISRCTN77249875niversity of Leeds (UK)100
尚未招募
不适用
A Study of Treatment-free remission Evaluation in Real-world chronic myeloid leukemia-Prospective observational studyKCT0007901Gachon University Gil Medical Center200
进行中（未招募）
不适用
A 3-Phase Study to Evaluate Sustained Remission and Productivity Outcomes in Subjects With Early Rheumatoid Arthritis Initiated on Treatment With Etanercept Plus Methotrexate - PRIZEModerate to severe early Rheumatoid Arthritis (RA).MedDRA version: 12.0Level: LLTClassification code 10039073Term: Rheumatoid arthritisEUCTR2008-002623-85-ITWyeth Research Division of Wyeth Pharmaceuticals Inc. Clinical Research and Development300
已完成
不适用
The evaluation of efficacy for remission maintenance with immunomodulator following remission induction with tacrolimus in patients with moderate to severe active refractory ulcerative colitis.:mucosal healing for prognosisThe patients with moderate to severe active refractory ulcerative colitisJPRN-UMIN000004201Osaka City University, Graduate School of Medicine,Department of Gastroenterology50